Aggressive Supportive Treatment for COVID-19 in Leukemia and MDS

New findings provide preliminary evidence to use aggressive supportive treatment of COVID-19 in patients with acute leukemias and myelodysplastic syndromes.

Related Keywords

United States ,New York ,American ,Gwen Nichols ,Pinkal Desai ,American Society Of Hematology ,Research Collaborative ,Medscape Coronavirus Resource Center ,Leukemia Lymphoma Society ,Coronavirus Resource ,American Society ,Weill Cornell Medicine ,Lymphoma Society ,Acute Leukemia ,Coronavirus ,019 Novel Coronavirus ,019 Ncov ,Uhan Coronavirus ,Uman Coronavirus Hku1 ,Uman Coronavirus Oc43 ,Cov Oc43 ,Uman Coronavirus 229e ,Cov 229e ,Covid 19 And Cancer ,Coronavirus And Cancer ,Myelodysplastic Syndrome ,Ads ,Hematology ,Leukemia ,Covid 19 Treatment ,Acute Myeloblastic Leukemia ,Cancer ,Alignant Neoplasia ,Arcinoma ,Intensive Care Unit Icu ,Intensive Care Un ,